4D Molecular Therapeutics (FDMT) EBIT (QoQ) (2020 - 2026)
4D Molecular Therapeutics (FDMT) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | 4D Molecular Therapeutics | 706.51 Mn | 315.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -600.31% |
| Dec 31, 2025 | 124.05% |
| Sep 30, 2025 | -2.91% |
| Jun 30, 2025 | -10.88% |
| Mar 31, 2025 | 4.45% |
| Dec 31, 2024 | -9.75% |
| Sep 30, 2024 | -20.44% |
| Jun 30, 2024 | -11.33% |
| Mar 31, 2024 | -4.05% |
| Dec 31, 2023 | -162.29% |
| Sep 30, 2023 | 56.52% |
| Jun 30, 2023 | -6.74% |
| Mar 31, 2023 | -4.83% |
| Dec 31, 2022 | -8.40% |
| Sep 30, 2022 | 6.79% |
| Jun 30, 2022 | -7.71% |
| Mar 31, 2022 | -6.57% |
| Dec 31, 2021 | -9.28% |
| Sep 30, 2021 | -198.33% |
| Jun 30, 2021 | 53.43% |